SMTL ID : 9uk4.1

Crystal structure of WDR5 in complex with peptide Ac-ARA-NH2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.12 Å

Oligo State

monomer

Ligands

1 x ACE- ALA- ARG- ALA- NH2: ACE-ALA-ARG-ALA-NH2(Non-covalent)

ACE-ALA-ARG-ALA-NH2.1: 15 residues within 4Å: Chain A: A.26, S.28, A.44, G.68, I.69, S.70, D.71, D.86, F.112, S.154, Y.239, C.240, F.242, I.284, L.300 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.26, A:A.44, A:F.112, A:F.112, A:I.284 Hydrogen bonds: A:S.70, A:D.86, A:S.154, A:C.240 Water bridges: A:S.70, A:Y.239 Salt bridges: A:D.71

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, M. et al., Therapeutic targeting of WDR5-MLL1 by EMBOW-derived peptides suppresses leukemia progression. Cell Chem Biol (2025)

Release Date

2025-10-08

Peptides

WD repeat-containing protein 5: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

WD repeat-containing protein 5

Related Entries With Identical Sequence